New Survey from Rite Aid Reveals Gaps in Consumer Awareness and Utilization of Pharmacist Expertise

PHILADELPHIA–(BUSINESS WIRE)–Rite Aid today released the results of a new survey* to better understand the ways in which consumers engage with their pharmacists, and uncover additional ways pharmacists can support their overall health. “As industry research shows, many consumers visit their pharmacist far more frequently than their healthcare provider as patient appointments can take weeks to secure,” said Karen Staniforth, Chief Pharmacy Officer at Rite Aid. “Over the years, I’ve seen firsth
Read More

Precision BioSciences Announces Complete Clinical Response in First Infant Dosed by Partner iECURE in Ongoing Phase 1/2 Clinical Trial in Ornithine Transcarbamylase (OTC) Deficiency

DURHAM, N.C.–(BUSINESS WIRE)–Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today announced that its partner iECURE has reported clinical efficacy and safety data in the first patient dosed with ECUR-506 in the Phase 1/2 OTC-HOPE study. ECUR-506 is iECURE’s in vivo gene insertion program
Read More

Availity, Concert Partner to Digitize and Automate Prior Authorization for Genetic Testing

JACKSONVILLE, Fla. & NASHVILLE, Tenn.–(BUSINESS WIRE)–Availity®, the nation’s leading real-time health information network, and Concert®, the leading provider of clinical content and payment accuracy solutions for advanced diagnostics, have partnered to digitize and automate the prior authorization and payment processes for genetic tests. Together the companies will enable more consistent, transparent, and instantaneous prior authorizations, reducing administrative burden in the delivery of p
Read More

Caregility Appoints New Chief Nursing Officer

WALL TOWNSHIP, N.J.–(BUSINESS WIRE)– #hybridcare–Caregility Corporation, an enterprise telehealth leader dedicated to connecting care for patients and clinicians everywhere through innovative virtual care and AI-powered solutions, today announced the appointment of Susan Kristiniak, DHA, MSN, RN, NEA-BC, AHN-BC, as its new Chief Nursing Officer (CNO). In her role, Susan will lead Caregility’s clinical team and play a pivotal role in expanding the company’s innovative solutions to help healthcare organizat
Read More

Unum Group Declares Quarterly Dividend of $0.420 Per Share of its Common Stock

CHATTANOOGA, Tenn.–(BUSINESS WIRE)–Effective January 9, 2025, the Unum Group (NYSE: UNM) Board of Directors declared a quarterly dividend of $0.420 per share on its common stock to be paid February 14, 2025, to stockholders of record as of January 24, 2025. About Unum Group Unum Group (NYSE: UNM), a leading international provider of workplace benefits and services, has been helping workers and their families thrive for more than 175 years. Through its Unum and Colonial Life brands, the compan
Read More

HITN offers free service providing medical support, Pregúntale a Lisa, to help California wildfire victims

BROOKLYN, N.Y.–(BUSINESS WIRE)–HITN is stepping up to assist those affected by the devastating wildfires in Los Angeles County by providing ‘Pregúntale a Lisa’, its free medical support service powered by Vida y Salud. ‘Pregúntale a Lisa’ is a platform that offers a free chat with doctors and an AI-powered health symptom checker. It provides accessible and accurate medical guidance to its users. ‘Pregúntale a Lisa’ is staffed by experienced medical professionals from Vida y Salud. Starting Th
Read More

AI platform identifies which patients are likely to benefit most from a cancer clinical trial

A study led by Winship Cancer Institute of Emory University and Abramson Cancer Center of the University of Pennsylvania researchers demonstrates that a first-of-its-kind platform using artificial intelligence (AI) could help clinicians and patients assess whether and how much an individual patient may benefit from a particular therapy being tested in a clinical trial.
Read More
Top